ArticleThe International journal of eating disorders2026
Effectiveness of Virtually Delivered Cognitive-Behavioral Therapy for Avoidant/Restrictive Food Intake Disorder.
Article in The International journal of eating disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Effectiveness of Virtually Delivered Cognitive-Behavioral Therapy for Avoidant/Restrictive Food Intake Disorder.The International journal of eating disorders · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
objectiveCognitive-behavioral therapy for ARFID (CBT-AR) has demonstrated preliminary efficacy in open trials, but no studies have examined its effectiveness in real-world settings. We evaluated the effectiveness of virtually delivered CBT-AR for adults with ARFID and examined whether baseline symptom severity within each ARFID profile predicted corresponding symptom improvement.
methodN = 549 adults with ARFID received CBT-AR through Equip Health. We collected weight and Pica, ARFID, and Rumination Disorder Interview-ARFID Questionnaire data at intake and throughout treatment. Ordinary least squares regressions examined changes in weight and ARFID symptoms, and whether baseline severity within each profile predicted improvement in that domain, controlling for severity in other profiles and demographic/clinical covariates.
resultsPatients requiring weight restoration (n = 243) gained an average of 0.34 lb (0.15 kg) per week (p < 0.001). In the full sample, patients demonstrated significant reductions in sensory sensitivity (b = -0.05, 95% CI [-0.07, -0.04]), fear of aversive consequences (b = -0.04, 95% CI [-0.05, -0.02]), and lack of interest in food/eating (b = -0.04, 95% CI [-0.05, -0.03]; all ps < 0.001). Greater baseline severity within each profile uniquely predicted greater improvement in the corresponding profile (all bs = -0.03, all ps < 0.001). DISCUSSION: CBT-AR delivered virtually under naturalistic conditions is effective for adults with ARFID, producing significant improvements in weight and ARFID symptoms. Though randomized controlled trials are needed to establish definitive efficacy, findings provide preliminary support for dissemination beyond specialized research settings and demonstrate the clinical utility of profile-based treatment planning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.